Thromboembolism and anticoagulation management in the preterm infant

Rajagopal R 1 , Cheah FC 2 , Monagle P 3

Affiliations 

  • 1 Pediatric Hemato-Oncology, Department of Pediatrics, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
  • 3 Department of Clinical Hematology, Department of Pediatrics, Royal Children's Hospital, University of Melbourne, Parkville, Victoria, Australia. Electronic address: Paul.Monagle@rch.org.au
Semin Fetal Neonatal Med, 2016 Feb;21(1):50-6.
PMID: 26553525 DOI: 10.1016/j.siny.2015.10.005

Abstract

The incidence of preterm thromboembolism has been increasing due to advances in diagnostic imaging which allow better detection of thrombi in sick preterm infants. At the same time, improvement in neonatal intensive care unit supportive care has increased the number of surviving and living preterm infants with thromboembolic risk factors. Disruption in the fine balance of hemostasis with potential risk factors, specifically septicemia and indwelling catheters, increase the occurrence of thromboembolic events. Treatment strategies in preterm infants are challenging due to limited data.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications